Centre Hospitalier Universitaire De Besancon
Clinical trials sponsored by Centre Hospitalier Universitaire De Besancon, explained in plain language.
-
Light-Based therapy may tame kidney transplant rejection
Disease control Recruiting nowThis study looks at whether a treatment called extracorporeal photopheresis can help kidney transplant recipients whose bodies are rejecting the new organ. The treatment involves filtering the patient's blood, treating it with a light-activated drug, and returning it to the body.…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for bile duct cancer: targeted combo trial launches
Disease control Recruiting nowThis study tests a new drug, MP0317, combined with standard chemotherapy and immunotherapy for people with advanced bile duct cancer that cannot be removed by surgery. The goal is to see if this combination helps keep the cancer from growing for at least 12 months. About 75 adult…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New vaccine combo aims to shrink liver tumors in advanced cancer
Disease control Recruiting nowThis study tests whether adding a cancer vaccine (UCPVax) to standard immunotherapy (atezolizumab and bevacizumab) can shrink tumors better than standard therapy alone in people with advanced liver cancer that cannot be removed by surgery. About 105 adults who have not had prior …
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Blood test could speed up colorectal cancer detection
Diagnosis Recruiting nowThis study is testing a new blood test to quickly identify people who may have colorectal cancer. It aims to help doctors decide who needs urgent care, especially when colonoscopy appointments are delayed. The study will include 400 adults who either had a positive stool test or …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
Blood test may spot pancreatic cancer early, study hopes
Diagnosis Recruiting nowThis study aims to find blood-based biomarkers that can distinguish malignant pancreatic lesions from benign ones. Researchers will analyze blood samples from 100 adults with benign pancreatic conditions and compare them to existing data from patients with pancreatic cancer. The …
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Exercise program aims to fix sleep in alcohol recovery
Symptom relief Recruiting nowThis study tests whether a supervised exercise program can improve sleep in people with alcohol use disorder. Forty adults with sleep problems will take part in activities like walking, cycling, and yoga. Researchers will track sleep quality, melatonin levels, and how well partic…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can we predict who will beat liver cancer with immunotherapy?
Knowledge-focused Recruiting nowThis study aims to find biological markers that can predict how well liver cancer patients respond to a combination of two immunotherapy drugs, tremelimumab and durvalumab. Researchers will follow 120 adults with advanced liver cancer who have not had prior systemic treatment. Th…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
Gamers' sleep under the microscope: new study tests measurement methods
Knowledge-focused Recruiting nowThis study aims to see if it's practical to measure sleep in adults who play video games regularly but don't have gaming disorder. Forty participants (gamers and non-gamers) will keep sleep and gaming diaries, wear a wrist monitor, and provide urine samples for melatonin testing.…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC